Dragani T A, Hirohashi S, Juji T, Kawajiri K, Kihara M, Ono-Kihara M, Manenti G, Nomoto T, Sugimura H, Genka K, Yokota J, Takahashi T, Mitsudomi T, Nagao M
National Cancer Center Research Institute, Tokyo, Japan.
Cancer Res. 2000 Sep 15;60(18):5017-20.
Pulmonary adenoma susceptibility 1 (Pas1), the major locus affecting inherited predisposition to lung tumor development in mice, maps near the Kras2 gene. We previously reported a significant association between a KRAS2/RsaI polymorphism and the risk and prognosis of lung adenocarcinoma (ADCA) in the Italian population. In the present case-control study, we examined 269 lung ADCA patients, 121 squamous cell lung carcinoma patients, and 632 healthy individuals (general population controls) in the Japanese population with genetic markers spanning approximately 1200 kb in the KRAS2 region. Allele-specific oligonucleotide hybridization revealed the same KRAS2/RsaI polymorphism associated with risk and prognosis as in Italian lung ADCA patients; the polymorphism was significantly associated with clinical stage (P < 0.001) and survival rate (log rank = 0.0014), confirming the mapping of PAS1 and pointing to the role of this locus in human lung cancer.
肺腺瘤易感性1(Pas1)是影响小鼠肺癌发生遗传易感性的主要基因座,定位于Kras2基因附近。我们之前报道过KRAS2/RsaI多态性与意大利人群肺腺癌(ADCA)的风险及预后之间存在显著关联。在本病例对照研究中,我们使用KRAS2区域中跨度约1200 kb的遗传标记,检测了日本人群中的269例肺ADCA患者、121例肺鳞状细胞癌患者以及632名健康个体(普通人群对照)。等位基因特异性寡核苷酸杂交显示,与意大利肺ADCA患者一样,该KRAS2/RsaI多态性与风险及预后相关;该多态性与临床分期(P < 0.001)及生存率(对数秩 = 0.0014)显著相关,证实了PAS1的定位,并表明该基因座在人类肺癌中的作用。